Open Scanner

Specify a stock or a cryptocurrency in the search bar to get a summary

Internet Computer ICP
Bitcoin Cash BCH
Litecoin LTC
Field stub for analysis

Abbott Laboratories

ABT
Current price
116.64 USD +2.31 USD (+2.02%)
Last closed 114.01 USD
Sector Healthcare
Industry Medical Devices
Exchange NYSE
Capitalization 202 391 404 544 USD
Yield for 12 month +13.58 %
1Y
3Y
5Y
10Y
15Y
ABT
21.11.2021 - 28.11.2021

Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The company provides generic pharmaceuticals for the treatment of pancreatic exocrine insufficiency, irritable bowel syndrome or biliary spasm, intrahepatic cholestasis or depressive symptoms, gynecological disorder, hormone replacement therapy, dyslipidemia, hypertension, hypothyroidism, Ménière's disease and vestibular vertigo, pain, fever, inflammation, and migraine, as well as provides anti-infective clarithromycin, influenza vaccine, and products to regulate physiological rhythm of the colon. It also offers laboratory and transfusion medicine systems in the areas of immunoassay, clinical chemistry, hematology, and transfusion; molecular diagnostics polymerase chain reaction instrument systems that automate the extraction, purification, and preparation of DNA and RNA from patient samples, and detect and measure infectious agents; point of care systems; cartridges for testing blood gas, chemistry, electrolytes, coagulation, and immunoassay; rapid diagnostics lateral flow testing products; molecular point-of-care testing for HIV, SARS-CoV-2, influenza A and B, RSV, and strep A; cardiometabolic test systems; drug and alcohol test, and remote patient monitoring and consumer self-test systems; and informatics and automation solutions for laboratories. In addition, the company provides pediatric and adult nutritional products; rhythm management, electrophysiology, heart failure, vascular, and structural heart devices for the treatment of cardiovascular diseases; diabetes care products, such as glucose and blood glucose monitoring systems; and neuromodulation devices for the management of chronic pain and movement disorders. Abbott Laboratories was founded in 1888 and is based in North Chicago, Illinois. Address: 100 Abbott Park Road, North Chicago, IL, United States, 60064-6400

Check your investment idea

Find the best to beat the market
TSLA TSLA Tesla Motors
AAPL AAPL Apple
MSFT MSFT Microsoft

Analytics

WallStreet Target Price

125.37 USD

P/E ratio

35.8892

Dividend Yield

1.89 %

Current Year

+40 109 000 000 USD

Last Year

+43 653 000 000 USD

Current Quarter

+10 241 000 000 USD

Last Quarter

+10 143 000 000 USD

Current Year

+22 230 000 000 USD

Last Year

+24 511 000 000 USD

Current Quarter

+5 715 000 000 USD

Last Quarter

+5 538 000 000 USD

Key Figures ABT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
EBITDA 10 462 999 552 USD
Operating Margin TTM 20.09 %
PE Ratio 35.8892
Return On Assets TTM 6.11 %
PEG Ratio 26.9797
Return On Equity TTM 15.11 %
Wall Street Target Price 125.37 USD
Revenue TTM 40 108 998 656 USD
Book Value 22.26 USD
Revenue Per Share TTM 23.05 USD
Dividend Share 2.08 USD
Quarterly Revenue Growth YOY 1.5 %
Dividend Yield 1.89 %
Gross Profit TTM 24 579 000 000 USD
Earnings Share 3.25 USD
Diluted Eps TTM 3.25 USD
Most Recent Quarter IV 2023
Quarterly Earnings Growth YOY 55 %
Profit Margin 14.27 %

Dividend Analytics ABT

Champion - 10+ consecutive years of dividend increases

Dividend growth over 5 years

128 %

Continuous growth

10 years

Payout Ratio 5 years average

60 %

Dividend History ABT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Forward Annual Dividend Rate 2.2
Ex Dividend Date 12.04.2024
Forward Annual Dividend Yield 1.89 %
Last Split Factor 10000:4798
Payout Ratio 46.85 %
Last Split Date 02.01.2013
Dividend Date 15.05.2024

Stock Valuation ABT

1 year
3 years
5 years
10 years
21.11.2021 - 28.11.2021
Trailing PE 35.8892
Forward PE 24.2718
Enterprise Value Revenue 5.0618
Price Sales TTM 5.046
Enterprise Value EBITDA 22.8579
Price Book MRQ 5.1904

Financials ABT

1 year
3 years
5 years
10 years
15 years
Results 2019 Dynamics
* The data for this period has not yet been published

Technical indicators ABT

For 52 weeks

89.24 USD 117.98 USD
50 Day MA 111.04 USD
Shares Short Prior Month 11 881 345
200 Day MA 104.98 USD
Short Ratio 2.36
Shares Short 12 703 258
Short Percent 0.74 %

Dynamics of changes in the value of assets

Stocks


MSFT

MSFT

402.79 USD Microsoft Corporation -0.45 (-0.11%)
Detailed analytics

ETF funds


S

SX7EEX

11.59 EUR iShares EURO STOXX Banks 30-15 UCITS ETF (DE) 0 (0%)
Detailed analytics

Metals


Gold

2031.07 USD Gold +9.2 (+0.46%)
Detailed analytics